XERIS BIOPHARMA HOLDINGS, INC.

Analyst Reco. Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
1.74 ^USD	-1.14%		-8.90%	-25.96%

Mar. 28	Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target	MT
Mar. 18	Xeris Biopharma Holdings, Inc.(NasdaqGS:XERS) added to S&P Pharmaceuticals Select Industry Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target	Mar. 28	MT
Craig-Hallum Initiates Xeris Biopharma Holdings at Buy Rating With $4.50 Price Target	23-08-28	MT
SVB Securities Trims Xeris Biopharma Price Target to $5 From $6, Maintains Outperform Rating	23-01-27	MT
Jefferies Starts Xeris Biopharma Holdings at Buy With $4 Price Target	22-10-21	MT
Craig-Hallum Starts Xeris Biopharma Holdings at Buy With $6.50 Price Target	22-04-28	MT
Mizuho Securities Adjusts Xeris Biopharma Holdings' Price Target to $6 From $8, Keeps Buy Rating	22-03-16	MT
SVB Leerink Adjusts Xeris Biopharma Holdings Price Target to $6 From $8, Maintains Outperform Rating	22-02-16	MT
SVB Leerink Raises Price Target on Xeris Biopharma Holdings to $8 From $6, Maintains Outperform Rating	21-12-31	MT
HC Wainwright Raises Price Target on Xeris Biopharma Holdings to $5.40 From $4.25, Maintains Buy Rating	21-12-31	MT
SVB Leerink Starts Xeris Pharmaceuticals at Outperform With $6 Price Target	21-11-17	MT
HC Wainwright Starts Xeris Pharmaceuticals at Buy With $4 Price Target	21-10-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer